摘要
目的探讨Child-Pugh评分和白蛋白一胆红素(ALBI)分级对肝细胞癌患者生存评估的预测价值。方法回顾性分析2013年6月至2018年6月郑州大学第二附属医院收治接受肝动脉化疗栓塞治疗的129例HCC患者临床资料。结果ALBI分级能够预测HCC患者的预后生存时间;ALBI分级对HCC患者预后生存时间的预测能力强于CP分级;ALBI-1级、ALBI-2级是影响HCC患者治疗后的独立危险因素。结论ALBI分级能有效预测HCC患者接受TACE治疗后的远期生存。
Objective To explore the predictive value of Child-Pugh score and albumin-bilirubin(ALBI)classification for survival assessment of patients with hepatocellular carcinoma.Methods The clinical data of 129 patients with HCC who underwent transcatheter arterial chemoembolization in the Second Affiliated Hospital of Zhengzhou University from June 2013 to June 2018 were retrospectively analyzed.Results ALBI classification can predict the prognostic survival time of HCC patients;ALBI classification has a better ability to predict the prognosis survival time of HCC patients than CP classification;ALBI-1 and ALBI-2 are independent risk factors that affect HCC patients after treatment.Conclusion ALBI classification can effectively predict the long-term survival of patients with HCC after TACE treatment.
作者
刘芳
周英发
LIU Fang;ZHOU Ying-fa(Second Affiliated Hospital of Zhengzhou University,Zhengzhou,Henan 450014)
出处
《智慧健康》
2020年第11期135-136,共2页
Smart Healthcare
